Nitrosamines - The LC/MS Edge 1st Edition: Indian Pharmaceutical Industry Perspective & Evolving Regulatory Landscape
Get ready for Nitrosamines - The LC/MS Edge, a series of virtual connect that explores the latest updates, insights, and technical knowledge on nitrosamines in India.
Join us for the first session, focused on the growing concern of nitrosamines in the Indian pharmaceutical industry. Learn about the perspective of Indian Pharmacopoeia on regulation, evolving market landscape, growth opportunities and the role of LC-MS/MS in nitrosamine assessment studies. Experts will discuss the perspectives of evolving regulations and how companies can adapt these solutions, followed by a Q&A discussion. Nitrosamines pose a significant risk to public health, making it crucial for companies to be aware of the latest regulations and market trends. Stay ahead of the curve and ensure compliance with latest regulatory requirements. Don't miss out on this valuable opportunity.
Why should you attend?
- Gain insights into the perspective of Indian Pharmacopoeia on assessment of nitrosamines.
- Understand the current market landscape and growth opportunities.
- Learn about compliance requirements and how to navigate them.
- Stay up-to-date on the latest trends and updates related to nitrosamines in India.
- Improve your professional development & scientific understanding by enhancing your knowledge and skills related to nitrosamines assessment workflows and LC/MS.
Presenter: Mr. Arvind Kumar Sharma (Scientific Assistant, Indian Pharmacopoeia Commission, Ministry of Health & Family Welfare - Government of India)
With six years of experience as a Scientific Assistant at Indian Pharmacopoeia Commission, he has played a key role in the current development of Indian Pharmacopoeia Reference Substances (IPRS) and Impurity Reference Substances. He has been engaged in the preparation and updating of draft monographs for publishing in Indian Pharmacopoeia (IP). Additionally, he has played a major role in the development of the latest edition of the National Formulary of India 2021 and has been involved in work related to the Pharmacovigilance Programme of India (PvPI). He holds a a M. Pharmacy in Pharmacology from Sinhgad Institute of Pharmaceutical Sciences, Pune and a B. Pharmacy from the College of Pharmacy, IPS Academy Indore. He has authored several articles published in international journals and organized and represented IPC at various national and international conferences and workshops. He has also participated in joint inspections for registration of manufacturing units and testing laboratories.
Presenter: Dr Kuldeep Sharma (Sales Development Manager - Pharma, Agilent Technologies India Pvt Ltd)
Kuldeep Sharma has over 19 years of experience in area/s of Bioanalytical research, Drug metabolism & pharmacokinetics and Pharma regulatory compliance. He has accomplished PhD in Biotechnology. His professional journey covers over 12 years in Analytical research (associated with R&D’s of Zydus Cadila, Lambda, Pliva and Jubilant Biosys) and last 7 years in analytical instruments sales, marketing & business development. With over 21 research articles published in international Journals, He presents convention of continues learning.
